Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul;28(7):727-732.
doi: 10.1111/iju.14548. Epub 2021 Mar 19.

Use of surgical checklist during transurethral resection increases detrusor muscle collection rate and improves recurrence-free survival in patients with non-muscle-invasive bladder cancer

Rikiya Taoka  1 , Hiroyuki Tsunemori  1 , Yuki Matsuoka  1 , Kana Kohashiguchi  1 , Takayoshi Miura  1 , Yoichiro Tohi  1 , Yasuyuki Miyauchi  1 , Takuma Kato  1 , Nobufumi Ueda  1 , Mikio Sugimoto  1
Affiliations

Use of surgical checklist during transurethral resection increases detrusor muscle collection rate and improves recurrence-free survival in patients with non-muscle-invasive bladder cancer

Rikiya Taoka et al. Int J Urol. 2021 Jul.

Abstract

Objective: To elucidate the therapeutic benefits of using a surgical checklist during transurethral resection for non-muscle-invasive bladder cancer.

Methods: A nine-item surgical checklist was established in January 2016 to assess disease risk and resection adequacy, and it was prospectively implemented into clinical practice. Patients diagnosed with non-muscle-invasive bladder cancer who underwent complete resection from January 2009 to August 2019 were included in this study. The presence of detrusor muscle in the transurethral resection specimen and the intravesical recurrence-free survival were compared between patients who underwent transurethral resection before and after surgical checklist implementation.

Results: A total of 125 patients who underwent transurethral resection after surgical checklist implementation were reviewed and compared with 125 patients who underwent transurethral resection before surgical checklist implementation. The use of the surgical checklist led to an increase in the proportion of transurethral resection specimens containing detrusor muscle (92% vs 69.6%, P < 0.01) and a decrease in the recurrence rate (19.2% vs 49.6%, P < 0.01). Multivariate analysis showed that transurethral resection without a surgical checklist was an independent predictive factor influencing the absence of detrusor muscle in the transurethral resection specimen (odds ratio 4.78, P < 0.01) and intravesical recurrence (hazard ratio 1.92, 95% confidence interval 1.14-3.23; P = 0.01). Kaplan-Meier plots showed that the recurrence-free survival rate was significantly lower when the surgical checklist was not used (log-rank test result P < 0.01).

Conclusions: This study shows the therapeutic benefits of surgical checklist in improving the quality of resection during transurethral resection and reducing the recurrence rate in patients with non-muscle-invasive bladder cancer.

Keywords: bladder cancer; non-muscle-invasive bladder cancer; recurrence-free survival; surgical checklist; transurethral resection of bladder tumor.

PubMed Disclaimer

Comment in

References

    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018; 68: 394-424.
    1. Abraham J, Gulley JL. The Bethesda Handbook of Clinical Oncology, 5th edn. Wolters Kluwer Health, Philadelphia, 2019.
    1. Babjuk M, Burger M, Compérat EM et al. European Association of Urology guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ) - 2019 update. Eur. Urol. 2019; 76: 639-57.
    1. Brausi M, Collette L, Kurth K et al. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur. Urol. 2002; 41: 523-31.
    1. Cumberbatch MGK, Foerster B, Catto JWF et al. Repeat transurethral resection in non-muscle-invasive bladder cancer: a systematic review. Eur. Urol. 2018; 73: 925-33.

LinkOut - more resources